Provided by Tiger Fintech (Singapore) Pte. Ltd.

Applied DNA Sciences

5.04
-0.1100-2.14%
Post-market: 4.98-0.0600-1.19%19:49 EDT
Volume:83.18K
Turnover:421.33K
Market Cap:2.62M
PE:0.00
High:5.42
Open:5.33
Low:4.98
Close:5.15
Loading ...

Applied DNA Sciences Q2 EPS $(15.35) Up From $(265.45) YoY, Sales $983.37K Up From $929.63K YoY

Benzinga
·
16 May

Applied DNA Sciences: Q2 Total Revenues $983 Thousand

THOMSON REUTERS
·
16 May

Applied DNA Sciences Reports 44% Increase in Therapeutic DNA Segment Revenues and $3.3 Million Net Loss for Q2 Fiscal 2025

Reuters
·
16 May

Applied DNA Sciences Inc. to Release Q2 Fiscal 2025 Financial Results and Host Investor Update Call

Reuters
·
14 May

Applied DNA Sciences Inc expected to post a loss of $3.00 a share - Earnings Preview

Reuters
·
14 May

Applied DNA Sciences Inc expected to post a loss of $3.00 a share - Earnings Preview

Reuters
·
10 May

Applied DNA Sciences Inc expected to post a loss of $3.00 a share - Earnings Preview

Reuters
·
07 May

Applied DNA’s LineaRx ‘ready to support’ reshoring of drug development

TIPRANKS
·
21 Apr

Applied DNA Sciences Regains Nasdaq Compliance on Minimum Bid Price Rule

MT Newswires Live
·
08 Apr

Applied DNA regains compliance with Nasdaq minimum bid price rule

TIPRANKS
·
08 Apr

Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement

ACCESS Newswire
·
08 Apr

Applied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety Announcement

ACCESS Newswire
·
01 Apr

Applied DNA Seeks New York Approval for H5 Bird Flu Test

MT Newswires Live
·
26 Mar

Applied DNA Submits Validation Package to New York State Department of Health for H5 Bird Flu/Pan-Influenza A Laboratory-Developed Test

ACCESS Newswire
·
26 Mar

Applied DNA Sciences trading halted, news pending

TIPRANKS
·
14 Mar

Analysts Offer Insights on Healthcare Companies: Anavex Life Sciences (AVXL) and Applied DNA Sciences (APDN)

TIPRANKS
·
28 Feb

Applied DNA Sciences Inc. Earnings Call Highlights Mixed Sentiment

TIPRANKS
·
15 Feb

Applied DNA Sciences Inc (APDN) Q1 2025 Earnings Call Highlights: Strategic Restructuring and ...

GuruFocus.com
·
14 Feb

Applied DNA Sciences Inc. Reports Restructuring and Revenue Growth

TIPRANKS
·
14 Feb

Applied DNA Sciences (APDN) Reports Q1 Loss, Tops Revenue Estimates

Zacks
·
14 Feb